NCT07449195 is a NA clinical trial of Intalight Dream OCT in Ocular Tumor, sponsored by Memorial Sloan Kettering Cancer Center.

Who is sponsoring NCT07449195?

NCT07449195 is sponsored by Memorial Sloan Kettering Cancer Center.

What drugs are being tested in NCT07449195?

Interventions in NCT07449195: Intalight Dream OCT, Heidelberg Spectralis OCT.

What condition does NCT07449195 study?

NCT07449195 studies Ocular Tumor.

Is NCT07449195 still recruiting?

NCT07449195 is currently recruiting now. Last updated 4 March 2026.

Last reviewed 2026-03-04 · How we verify

NCT07449195

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors

Recruiting now NA Last updated 4 March 2026

What this trial tests

NA trial testing Intalight Dream OCT in Ocular Tumor in 60 participants. Currently enrolling.

Timeline

27 February 2026

Primary endpoint
27 February 2028

27 February 2028

Quick facts

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	60
Start date	27 February 2026
Primary completion	27 February 2028
Estimated completion	27 February 2028
Sites	7 locations across United States

Drugs / interventions tested

Intalight Dream OCT
Heidelberg Spectralis OCT

Conditions studied

Ocular Tumor — all drugs for Ocular Tumor →

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

18 and older, any sex, with Ocular Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ocular Tumor

Currently open trials in the same condition.

NCT05051384 — Superb Microvascular Intraocular Tumor Imaging Study (SMITIS) · NA · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
NCT07454382 — A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07449195 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 4 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07449195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing